300 related articles for article (PubMed ID: 3938085)
1. Medical therapy in the prevention of cataract.
Brown NA; Bron AJ
Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 7)():748-54. PubMed ID: 3938085
[TBL] [Abstract][Full Text] [Related]
2. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
Datiles M; Fukui H; Kuwabara T; Kinoshita JH
Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
[TBL] [Abstract][Full Text] [Related]
3. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
Jacobson M; Sharma YR; Cotlier E; Hollander JD
Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
[TBL] [Abstract][Full Text] [Related]
4. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
Christensen JE; Larsen AB; Gregersen G
Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
[No Abstract] [Full Text] [Related]
5. Differences in the susceptibility of various aldose reductases to inhibition. II.
Kador PF; Kinoshita JH; Tung WH; Chylack LT
Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
Unakar N; Tsui J; Johnson M
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
[TBL] [Abstract][Full Text] [Related]
7. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
Datiles MB; Fukui H
Curr Eye Res; 1989 Mar; 8(3):233-7. PubMed ID: 2523284
[TBL] [Abstract][Full Text] [Related]
8. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
Ono H; Nozawa Y; Hayano S
Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
[No Abstract] [Full Text] [Related]
9. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
Hotta N; Sakamoto N
Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
[No Abstract] [Full Text] [Related]
10. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
Sima AA; Bril V; Nathaniel V; McEwen TA; Brown MB; Lattimer SA; Greene DA
N Engl J Med; 1988 Sep; 319(9):548-55. PubMed ID: 3136331
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
[No Abstract] [Full Text] [Related]
12. Nonosmotic diabetic cataracts.
Malone JI; Lowitt S; Cook WR
Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
[TBL] [Abstract][Full Text] [Related]
13. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E; Varagiannis E
Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
[TBL] [Abstract][Full Text] [Related]
14. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E
Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
[TBL] [Abstract][Full Text] [Related]
15. [Aldose-reductase inhibitors and cataract formation (author's transl)].
Keller G; Leuenberger PM
Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
[TBL] [Abstract][Full Text] [Related]
16. Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy.
Mizuno A; Nozawa H; Yaginuma T; Matsuzaki H; Ozaki Y; Iriyama K
Exp Eye Res; 1987 Jul; 45(1):185-6. PubMed ID: 3115805
[No Abstract] [Full Text] [Related]
17. The effect of aldose reductase and its inhibition on sugar cataract formation.
Kador PF; Akagi Y; Kinoshita JH
Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204
[TBL] [Abstract][Full Text] [Related]
18. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
Nozawa H; Yaginuma T; Mizuno A
Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
[No Abstract] [Full Text] [Related]
19. Potential use of aldose reductase inhibitors to prevent diabetic complications.
Zenon GJ; Abobo CV; Carter BL; Ball DW
Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
Sato S; Mori K; Wyman M; Kador PF
Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
